Fact check: Hydroxychloroquine does not work better

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks
180
Fact check: Hydroxychloroquine does not work better abroad

Ella Lee

USA TODAY

https://www.usatoday.com/story/news/factcheck...311483001/

The claim: Hydroxychloroquine works in other countries, but not in the U.S.

As some global leaders tout the effectiveness of hydroxychloroquine against COVID-19, scientists from those countries caution that there’s not much evidence it works, putting the drug at the center of political debate.

A meme shared by The Rabbit Hole, a Facebook page that often reposts right-wing memes and often veers into QAnon territory, claims that while top U.S. medical professionals say the drug doesn’t work, it’s working just fine in other countries.

“Hydroxychloroquine works in Spain, Italy, Brazil. Mexico, France, Germany & elsewhere,” the Facebook post reads. “The only place hydroxychloroquine does not work is the USA, according to Dr. Fauci.”

The post has been shared over 2,300times, and comments criticize the renouncement of the drug by Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.

“The man has sold his soul, he now works for the Dems in big Pharma! Needs to be replaced” one commenter wrote.

Fact check:Hydroxychloroquine has not worked in treating COVID-19, studies show

Hydroxychloroquine is no more effective abroad than in the U.S.
Hydroxychloroquine is an immunosuppressive drug that was developed decades ago to prevent and treat malaria. It’s also used to treat autoimmune diseases like systemic lupus erythematous and rheumatoid arthritis.


The drug made its way into mainstream conversation after some global leaders, including President Donald Trump, claimed it could be a COVID-19 treatment.

But many scientists and studies have made it clear the drug has not worked in treating COVID-19 – and might even be dangerous.

Fact check:'Thousands' of doctors have not said hydroxychloroquine cures COVID-19


France, Italy and Belgium all moved to stop the use of hydroxychloroquine in May , shortly after the World Health Organization decided to pause a large trial of the drug due to safety concerns. WHO has now discontinued that trial. Germany paused its trial for the same reasons, but is now conducting one trial in patients with mild cases of COVID-19.

Brazil President Jair Bolsonaro, who contracted COVID-19 in early July, has pushed for Brazilians to use hydroxychloroquine, saying he used it for his own treatment.

“This was my experience,” he said. “Twelve hours after taking that first dose of hydroxychloroquine, I was 100% better. So, it worked for me. I’m the living proof.”

But scientists in Brazil say there’s no hard evidence hydroxychloroquine is working there. A clinical trial conducted at 55 hospitals across Brazil found the drug to be ineffective, according to a study published July 23 in the New England Journal of Medicine .

In May, Mexico received a donation of hydroxychloroquine that it used to treat 20,000 patients Forbes Mexico reported. Mexico also tops the list of most expensive purchases of hydroxychloroquine, Mexican newspaper La Jornada reported.

But in July, Gustavo Reyes Terán, head of the Coordinating Commission of the National Institutes of Health and High Specialty Hospitals in Mexico, said that there was no evidence the drug works against COVID-19, Milenio, a Spanish-language magazine, reported.


“Hydroxychloroquine is one of the drugs that does have an in-vitro effect in the test tube," he said. "Experimenting with cells reduces viral infection and also has an anti-inflammatory effect. In theory, it was one of the ideal drugs, but when it is carried in a clinical trial it is different, in the human body it is different. Hydroxychloroquine has not shown efficacy."

When most countries stopped testing hydroxychloroquine, Spaincontinued to use the drug against the coronavirus, according to El País, a Spanish-language daily newspaper in Spain. But after putting the drug through tests, top Spanish scientists found the drug failed as a method to prevent COVID-19.

The countries using or lauding hydroxychloroquine as a treatment — Mexico, Spain, Brazil and the U.S. — are not doing any better than other countries taking different approaches and are ranked as needing action, according to data from EndCoronavirus.org, an international coalition of several thousand volunteers, including scientists and community organizers.

Fauci says hydroxychloroquine does not work, studies back him up

Facebook page The Rabbit Hole pointed to a study put out by the Henry Ford Hospital System in southeast Michigan in response to USA TODAY’s request for comment. That study, released July 2, found that death rates were 50% lower among patients treated with hydroxychloroquine and that the drug posed no safety problems.

Fauci and others called the study flawed, pointing to a number of issues.


"The Henry Ford hospital study ... was confounded by a number of issues, including the fact that many of the people who are receiving hydroxychloroquine were also receiving corticosteroids, which we know from another study gives a clear benefit in reducing deaths with advanced disease," Fauci said during a congressional hearing July 31.

"So that study is a flawed study. ... When I do see a randomized placebo-controlled trial that looks at any aspect of hydroxychloroquine — either early study, middle study or late — if that randomized placebo-controlled trial shows efficacy, I would be the first one to admit it and to promote it."

The study was also criticized as an observational study, which is less rigorous than a randomized trial, USA TODAY reported.

In response to the criticism, the Henry Ford Health System released an open letter, citing its dismay that the current political climate has “made any objective discussion about this drug impossible.”

Multiple other studies have backed up Fauci’s statements, USA TODAY reported.

Our rating: False

We rate the claim that hydroxychloroquine works in other countries, but not in the U.S., as FALSE because it was not supported by our research. None of the countries listed have seen success greater than or equal to the U.S. in treating COVID-19 with the drug. Studies show the drug does not work, and Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, backs up that fact.

Our fact-check sources:

Medline Plus, June 15, Hydroxychloroquine
President Donald Trump tweet, March 21
USA TODAY, July 21, Fact check: Hydroxychloroquine has not worked in treating COVID-19, studies show
Reuters, May 27, France, Italy, Belgium to stop use of hydroxychloroquine for coronavirus over safety fears
The Guardian, May 25, WHO halts hydroxychloroquine trial for coronavirus amid safety fears
World Health Organization, July 4, WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19
Reuters, May 28, Germany pauses anti-malaria drug study for COVID-19: Spiegel
ClinicalTrials.gov, May 11, Hydroxychloroquine for the Treatment of Mild COVID-19 Disease (COMIHY)
BBC News, July 8, Coronavirus: Brazil's President Bolsonaro tests positive
The World, July 22, Why is Brazil's Bolsonaro peddling hydroxychloroquine despite the science?
The New England Journal of Medicine, July 23, Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
Mexico News Daily, May 23, Despite doubts, Mexico to administer hydroxychloroquine to 20,000
WION News, May 28, Spain will not stop use of HCQ to treat COVID-19 patients, unlike other European nations
Forbes Mexico, May 11, Novartis dona hidroxicloroquina en México para hacer pruebas en 20,000 pacientes con Covid-19
La Jornada, July 6, Los medicamentos se encarecen hasta 60%
Milenio, July 9, Estos son los fármacos que no han mostrado efectividad contra el covid-19
El Pais, May 27, España seguirá usando la hidroxicloroquina frente al coronavirus pese a la prohibición de Francia y las dudas de la OMS
El Pais, June 12, La hidroxicloroquina fracasa como método para prevenir la covid-19, según el ensayo de Oriol Mitjà
EndCoronavirus.org, accessed Aug. 18
Henry Ford Health System, July 2, Treatment with Hydroxychloroquine Cut Death Rate Significantly in COVID-19 Patients, Henry Ford Health System Study Shows
PBS News Hour on YouTube, July 31, Widely cited hydroxychloroquine study is ‘flawed’, Fauci tells hearing
Henry Ford Health System, Aug. 3, Hydroxychloroquine: An Open Letter to Our Community and Beyond
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stephanie Knepp Joins Exceptional Women Alliance

Updated Category News Views 81

A New Chapter for a Seasoned Leader When a high flyer like Stephanie Knepp steps into a new arena, you know folks are going to sit up and pay attention. This time, she's making waves by joining the Exceptional Women Alliance (EWA), a heavy-hitting community of women leaders. With her extensive background in scaling businesses and empowering leaders, she's bound to bring...

Continue Reading
MINISO Prepares to Reveal September 2026 Results

Updated Category News Views 95

News flash, folks — MINISO Group, that quirky IP-driven retailer we all have an eye on, has set the stage for its next big reveal. Come November 17, 2026, they’re gonna lay down their financial cards for the September quarter. It’s prime time for any investor keen on dissecting their performance and plans for the future. What the Call Means for Stakeholders MINISO's...

Continue Reading
Are Insider Deals Jipping OPCH, PTC, RXO Shareholders?

Updated Category News Views 17

Let's Scrutinize These Big Transactions Alright, let's cut to the chase. We're seeing some big moves from Option Care Health, PTC Inc., and RXO Inc. that have us wondering if the shareholders are getting the short end of the stick. That's what Halper Sadeh LLC seems to think. They're rolling up their sleeves, investigating whether these companies have tossed aside their...

Continue Reading
Synova Global Taps Eventus for Top Trade Surveillance

Updated Category News Views 89

Synova and Eventus: A Powerful Partnership If you've ever traded a share or two, you know the name of the game is risk management. Step into Synova Global's latest move, and you'll see a gamble worth watching closely. This time around, Synova has tapped Eventus to bring their Validus trade surveillance platform into the fold. Now, Eventus and its star player, Validus,...

Continue Reading
Wincomm & Portwell Unveil Medical AI Tech at MEDICA 2026

Updated Category News Views 51

MEDICA 2026: Wincomm and Portwell Join Forces November's got one heck of an event lined up with MEDICA 2026, where Wincomm and Portwell are teaming up to showcase what they've got up their sleeves in medical AI computing. This whole shebang runs from November 16 to 19, with their setup in Hall 12, Stand C76, Düsseldorf, Germany. But why should investors care? Because...

Continue Reading
Handle Plumbing Emergencies Swiftly, Expert Advises

Updated Category News Views 62

Fast Response Crucial in Plumbing Crises It's like nature's way of testing your mettle: a sudden plumbing emergency can make any homeowner feel like they're in over their head. The trick lies in how fast you act, and let me tell you, speed is everything in these situations. If you’ve never stared down a burst pipe or felt your heart drop at an overflowing toilet,...

Continue Reading
Asia-Pacific Tackles Aging: Cooperation and Innovations

Updated Category News Views 95

Aging Population Poses Global Challenge Population aging is riding the forefront of some serious conversations lately, with the 2026 Asia-Pacific Regional Conference on Population Ageing in Hangzhou underscoring just how big this wave is—and will be. Held at the end of October, this gathering wasn’t just folks sitting around a table. They were hammering out what the...

Continue Reading
Meteor Education Bolsters CTE Reach with AET Labs Buy

Updated Category News Views 85

Meteor's Move: AET Labs Picked Up in CTE Plays You see, Meteor Education ain't sitting on its hands, that's for sure. They're out here hoarding strategic pieces like it's a chess match, snatching up AET Labs to bolster their already sturdy CTE playbook. No financial details spilled, but hell, that’s par for the course. This move plants them even more firmly in New...

Continue Reading
Business Formations in 2026: A Blow-by-Blow Analysis

Updated Category News Views 74

Surging Entrepreneurial Spirit in 2026 Just when you’d think economic jitters would slow us down, American entrepreneurship is out there smashing records like a bulldozer through a picket fence. September 2026 saw a staggering 562,579 new business formations—the highest September tally ever logged. That's no fluke. This momentum hasn’t let up all year, and it paints...

Continue Reading
GreenCore's Agentic Shopping Hub: Disrupting FMCG Market

Updated Category News Views 0

GreenCore's Bold Move in FMCG Retail Just when you thought retail couldn't get any more futuristic, here comes GreenCore Solutions Corp. (GSC) shaking up the game with their Agentic Shopping Hub. For the uninitiated, we're not just talking about another e-commerce gimmick—this is a cultural shift. FMCG brands are being told to 'bring their agent' into a realm where AI...

Continue Reading

Top 5 Most Recently Viewed Articles

New Leadership at River Valley Community Bancorp: Sinclair Joins Board

Updated Category News Views 216

River Valley Community Bancorp Welcomes New Director River Valley Community Bancorp (OTC markets: RVCB) has exciting news regarding its board of directors. The bank has successfully appointed Robert F. Sinclair as a member of the board, an announcement that has generated positive buzz within the community. This transition is effective from the beginning of next month,...

Continue Reading
Investigation Announced for Fermi Inc. After IPO Issues

Updated Category News Views 102

Edelson Lechtzin LLP Begins Investigation into Fermi Inc. Edelson Lechtzin LLP is actively investigating potential infractions of federal securities regulations concerning Fermi Inc. (NASDAQ: FRMI). Allegations have surfaced regarding the company possibly disseminating misleading business information that misinformed investors. The Background of Fermi Inc. Fermi Inc....

Continue Reading
UFC GYM® Expands Globally with 45 New Locations in 2025

Updated Category News Views 809

UFC GYM® Sets the Stage for Global Expansion UFC GYM® is embarking on an exciting journey in the coming year, with plans to open over 45 locations worldwide. This ambitious expansion reflects the brand's commitment to making its unique fitness experience available in 42 countries across the globe. As UFC GYM continues to revolutionize both the fitness and mixed martial...

Continue Reading
Maximus Wins $300 Million IRS Contract for Enhanced Services

Updated Category News Views 152

Maximus Earns a $300 Million IRS Contract Maximus (NYSE: MMS), a leading government services provider, has recently been selected by the Internal Revenue Service (IRS) for a significant Blanket Purchase Agreement (BPA) worth $300 million. This BPA, which spans a total of five years, allows Maximus to offer vital Non-IT Consulting Services aimed at improving the taxpayer...

Continue Reading
TROOPS, Inc. Expands Horizons with Strategic Taiwan Acquisition

Updated Category News Views 126

TROOPS, Inc. Expands Horizons with Strategic Taiwan Acquisition TROOPS, Inc. (NASDAQ: TROO), a prominent player in diverse business sectors, has announced a significant upcoming acquisition. Its subsidiary, Giant Connection Limited, has entered into a Letter of Intent with WORLD HONOR HOLDINGS LIMITED to acquire a 49% stake in WORK, Inc., a co-working space operator based...

Continue Reading